79
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Biomimetic Particles in Drug and Vaccine Delivery

Pages 165-172 | Received 31 May 2007, Accepted 06 Jun 2007, Published online: 09 Dec 2008
 

Abstract

Over the last two decades, lipid supramolecular association to particles has been systematically studied on latex, silica or drug particles over a range of experimental conditions in order to achieve optimal bilayer deposition onto particles. The difficult step of vesicle disruption, especially for bilayers in the rigid gel state, was circumvented by using previously disrupted charged vesicles, namely, charged bilayer fragments or disks. Thereby, under appropriate conditions of the intervening medium, bilayer fragments coalesced around particles. In this mini-review, some applications of biomimetic particles in drug and vaccine delivery are discussed such as: encapsulation of hydrophobic drug particles, isolation and reconstitution of cell receptor function, presentation of antigens to the immunological system or highly effective antimicrobial action of positively charged bilayer disks by themselves or upon coverage of hydrophobic antimicrobial drug particles with the cationic bilayer fragments. In summary, a myriad of novel applications for spherical or discoidal biomimetic particles can be anticipated from the proofs-of-concept discussed in this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.